Aug 27, 2026 | News
September 26, 2026 – The Substance Abuse Services Administration (SAMHSA) has released a new publication: “Current Research, Regulatory, and Policy Considerations Regarding Psychedelics as Medicine”. Psychedelic-assisted therapy is moving from...Jul 28, 2026 | News
July 28, 2026 – Yesterday the Substance Abuse and Mental Health Services Administration (SAMHSA) released the results of the 2025 National Survey on Drug Use and Health (NSDUH), the nation’s primary source of data on how people living in the United States report...Jul 24, 2026 | News
Case Western Reserve University is offering an online class via Zoom “Controlled Drug Prescribing: Essential Aspects of Investigation” on December 10, 2026 that may be of interest that is targeted for Medical, Nursing and Pharmacy Board Investigators,...Jul 11, 2026 | News
July 10, 2026 – The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined registration pathway for distributed manufacturing establishments that operate as a single establishment using a “hub-and-spoke”...Jul 11, 2026 | News
This link includes the formal press release – Office of Public Affairs | Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research...Jul 2, 2026 | News
July 1, 2026 – Yesterday the U.S. Drug Enforcement Administration filed its intent to temporarily place 7-hydroxymitagynine (7-OH) and three related substances into Schedule I of the Controlled Substances Act (CSA). Prior to DEA issuing this notice, the...